Oruka Therapeutics (ORKA) Current Deferred Revenue (2010 - 2013)
Oruka Therapeutics' quarterly Current Deferred Revenue came in at $3000.0 in Q2 2013, down 90.91% year-on-year from $33000.0 in Q2 2012, and down 62.5% quarter-over-quarter from $8000.0 in Q1 2013.
Oruka Therapeutics has reported Current Deferred Revenue for 4 years, with the latest figure at $3000.0 in Q2 2013.
- For the quarter ending Q2 2013, Current Deferred Revenue fell 90.91% year-over-year to $3000.0; the trailing twelve-month figure through Jun 2013 stood at $3000.0 (down 90.91% YoY), and the FY2012 full-year result was $16000.0, down 51.52% from the prior year.
- Current Deferred Revenue for Q2 2013 stood at $3000.0, down from $8000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $121000.0 in Q4 2010, with the low at $3000.0 in Q2 2013.
- Average Current Deferred Revenue over 4 years is $33600.0, with a median of $32500.0 recorded in 2011.
- Year-over-year, Current Deferred Revenue changed 0.0% in 2012 and plunged 90.91% in 2013.
- Tracing ORKA's Current Deferred Revenue over 4 years: stood at $121000.0 in 2010, then slumped by 72.73% to $33000.0 in 2011, then tumbled by 51.52% to $16000.0 in 2012, then plunged by 81.25% to $3000.0 in 2013.
- The last three Current Deferred Revenue figures came in at $3000.0 (Q2 2013), $8000.0 (Q1 2013), and $16000.0 (Q4 2012), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 3,000.00 |
| Mar 31, 2013 | 8,000.00 |
| Dec 31, 2012 | 16,000.00 |
| Sep 30, 2012 | 24,000.00 |
| Jun 30, 2012 | 33,000.00 |
| Mar 31, 2012 | 33,000.00 |
| Dec 31, 2011 | 33,000.00 |
| Sep 30, 2011 | 32,000.00 |
| Jun 30, 2011 | 33,000.00 |
| Dec 31, 2010 | 121,000.00 |